Amarin Corp Plcuk (AMRN) Shares Repurchased (2015 - 2016)
Amarin Corp Plcuk (AMRN) reported Shares Repurchased of $694000.0 for Q1 2016, up 493.16% year-over-year from $117000.0 in Q2 2015, and up 1513.95% quarter-over-quarter from $43000.0 in Q4 2015.
Amarin Corp Plcuk (AMRN) Shares Repurchased (2015 - 2016) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 2 years of Shares Repurchased data on file, last reported at $694000.0 in Q1 2016.
- Shares Repurchased for Q1 2016 came in at $694000.0, up 493.16% year-over-year; the trailing twelve-month figure through Mar 2016 was $771000.0 (changed N/A YoY), and the FY2015 annual result was $194000.0, changed N/A from the prior year.
- Shares Repurchased improved to $694000.0 in Q1 2016 per AMRN's latest filing, from $43000.0 in the prior quarter.
- Over five years, Shares Repurchased peaked at $694000.0 in Q1 2016 and troughed at $34000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -439.51 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 2.36 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 4.03 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 1.49 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 874.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 419.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 694,000.00 |
| Mar 31, 2016 | 694,000.00 |
| Dec 31, 2015 | 43,000.00 |
| Dec 31, 2015 | 43,000.00 |
| Sep 30, 2015 | 34,000.00 |
| Sep 30, 2015 | 34,000.00 |
| Mar 31, 2015 | 117,000.00 |
| Mar 31, 2015 | 117,000.00 |